Compare James Hardie Industries plc. Ordinary Shares (JHX) vs Nuvation Bio Inc. Class A Common Stock (NUVB) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
James Hardie Industries plc. Ordinary Shares vs Nuvation Bio Inc. Class A Common Stock — how do they compare? James Hardie Industries plc. Ordinary Shares trades at $25.06 (market cap $14.60B), while Nuvation Bio Inc. Class A Common Stock trades at $4.99 (market cap $1.74B). The key difference: James Hardie Industries plc. Ordinary Shares is far larger — about 8.4× Nuvation Bio Inc. Class A Common Stock's market cap, and James Hardie Industries plc. Ordinary Shares is trading nearer its 52-week high, Nuvation Bio Inc. Class A Common Stock nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold James Hardie Industries plc. Ordinary Shares for 1 Days and Nuvation Bio Inc. Class A Common Stock for 1 Days on average.
| JHX | NUVB | |
|---|---|---|
Market Cap | $14.60B | $1.74B |
Volume | 7,262,924 | 9,289,619 |
Sector | Basic Materials | Health |
52-Week High | $31.08 | $9.54 |
52-Week Low | $16.69 | $3.41 |
Typical Hold Time | 1 Days | 1 Days |
Enterprise Value | $18.83B | $1.33B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About James Hardie Industries plc. Ordinary Shares
James Hardie manufactures fiber cement products for residential and commercial construction. Its portfolio includes exterior siding, interior boards, and other building materials.
Read more on JHX →About Nuvation Bio Inc. Class A Common Stock
Nuvation Bio Inc. is a biopharmaceutical company focused on oncology, developing novel cancer treatments including taletrectinib (marketed as IBTROZI), a ROS1 inhibitor, and safusidenib, a brain-penetrant IDH1 inhibitor.
Read more on NUVB →
